![Joseph Oliveto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Oliveto
Directeur Général chez
MILESTONE PHARMACEUTICALS INC.
Fortune : 633 666 $ au 31/05/2026
Profil
Mr. Joseph G.
Oliveto is a President & Chief Executive Officer at Milestone Pharmaceuticals USA, Inc. and a President, Chief Executive Officer & Director at Milestone Pharmaceuticals, Inc. He is on the Board of Directors at Milestone Pharmaceuticals, Inc. Mr. Oliveto was previously employed as a Chief Executive Officer & Director by Galleon Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Chelsea Therapeutics International Ltd., an Executive-in-Residence by A. M.
Pappas & Associates LLC, and a Director-Global Alliance by Hoffmann-La Roche, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 446 244 ( 0,36 % ) | 633 666 $ | 31/05/2026 |
Postes actifs de Joseph Oliveto
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Directeur Général | 07/03/2017 |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular drugs | Directeur Général | 07/03/2017 |
Anciens postes connus de Joseph Oliveto
| Sociétés | Poste | Fin |
|---|---|---|
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Directeur Général | 01/06/2016 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Directeur Général | 23/06/2014 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Corporate Officer/Principal | 30/06/2008 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | 01/01/2008 |
Formation de Joseph Oliveto
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular drugs | Health Technology |
